neurostimulation
Meaningful, Durable Long-Term Outcomes Seen With Restorative Neurostimulation
LAS VEGAS—Restorative neurostimulation can result in clinically meaningful and durable outcomes in patients ...
JUNE 12, 2024
3-Year Data Support Implanted Restorative Neurostimulation
ORLANDO, Fla.—A three-year follow-up of an implanted restorative neurostimulation clinical trial found ...
AUGUST 28, 2023
3-Year Data Support Implanted Restorative Neurostimulation
ORLANDO, Fla.—A three-year follow-up of an implanted restorative neurostimulation clinical trial found ...
JUNE 12, 2023
Wearable Neurostimulation Device Receives Second Chronic Pain Breakthrough Designation From FDA
The FDA gave a wearable neurostimulation device a breakthrough designation for reducing moderate to severe ...
JANUARY 28, 2022
Restorative Neurostimulation Demonstrates Safe, Lasting Relief in Refractory LBP Patients
An international multicenter study concluded that restorative neurostimulation is safe, effective and durable among ...
MAY 25, 2021
Wearable Neurostimulation Device Shown to Reduce Opioid Withdrawal Symptoms
New research has demonstrated the viability of transcutaneous transauricular neurostimulation to reduce the ...
MAY 21, 2021
Early Research Finds Better Patient Satisfaction With Multimodal SCS
New research has concluded that the use of a spinal cord stimulation system capable of multiple neurostimulation ...
SEPTEMBER 10, 2020
FDA Approves Integrated SCS Smartphone App
The FDA has approved a smartphone application that links Abbott neuromodulation devices to a variety of Apple ...
JULY 28, 2020
FDA Approves Neurostimulation System for Chronic Low Back Pain
The FDA has approved the Premarket Approval application for ReActiv8, an implantable neurostimulation system ...
JUNE 23, 2020
Neurostimulation Implant Improves Pain Catastrophizing and Depression
Two prospective multicenter studies of a recently FDA-approved recharge-free neurostimulation implantable system ...
MAY 22, 2020
FDA Approves ‘Low-Dose,’ Recharge-Free Neurostimulation System
The FDA approved the recharge-free neurostimulation system for the treatment of chronic pain.
OCTOBER 7, 2019
Study Finds High-Frequency SCS Effective In Reducing Opioid Dose for Managing Pain
A retrospective study comparing high-frequency (10-kHz) spinal cord stimulation with conventional medical ...
MARCH 21, 2019
